» Articles » PMID: 36250629

Discrete GPCR-triggered Endocytic Modes Enable β-arrestins to Flexibly Regulate Cell Signaling

Overview
Journal Elife
Specialty Biology
Date 2022 Oct 17
PMID 36250629
Authors
Affiliations
Soon will be listed here.
Abstract

β-Arrestins are master regulators of cellular signaling that operate by desensitizing ligand-activated G-protein-coupled receptors (GPCRs) at the plasma membrane and promoting their subsequent endocytosis. The endocytic activity of β-arrestins is ligand dependent, triggered by GPCR binding, and increasingly recognized to have a multitude of downstream signaling and trafficking consequences that are specifically programmed by the bound GPCR. However, only one biochemical 'mode' for GPCR-mediated triggering of the endocytic activity is presently known - displacement of the β-arrestin C-terminus (CT) to expose clathrin-coated pit-binding determinants that are masked in the inactive state. Here, we revise this view by uncovering a second mode of GPCR-triggered endocytic activity that is independent of the β-arrestin CT and, instead, requires the cytosolic base of the β-arrestin C-lobe (CLB). We further show each of the discrete endocytic modes is triggered in a receptor-specific manner, with GPCRs that bind β-arrestin transiently ('class A') primarily triggering the CLB-dependent mode and GPCRs that bind more stably ('class B') triggering both the CT and CLB-dependent modes in combination. Moreover, we show that different modes have opposing effects on the net signaling output of receptors - with the CLB-dependent mode promoting rapid signal desensitization and the CT-dependent mode enabling prolonged signaling. Together, these results fundamentally revise understanding of how β-arrestins operate as efficient endocytic adaptors while facilitating diversity and flexibility in the control of cell signaling.

Citing Articles

Spatial and signaling overlap of growth factor receptor systems at clathrin-coated sites.

Alfonzo-Mendez M, Strub M, Taraska J Mol Biol Cell. 2024; 35(11):ar138.

PMID: 39292879 PMC: 11617105. DOI: 10.1091/mbc.E24-05-0226.


Crosstalk of growth factor receptors at plasma membrane clathrin-coated sites.

Alfonzo-Mendez M, Strub M, Taraska J bioRxiv. 2024; .

PMID: 38903101 PMC: 11188102. DOI: 10.1101/2024.05.16.594559.


Neuroprotective Effects of Noncanonical PAR1 Agonists on Cultured Neurons in Excitotoxicity.

Babkina I, Savinkova I, Molchanova T, Sidorova M, Surin A, Gorbacheva L Int J Mol Sci. 2024; 25(2).

PMID: 38279219 PMC: 10816171. DOI: 10.3390/ijms25021221.


Altered Signaling and Desensitization Responses in PTH1R Mutants Associated with Eiken Syndrome.

Portales-Castillo I, Dean T, Cheloha R, Creemer B, Vilardaga J, Savransky S Commun Biol. 2023; 6(1):599.

PMID: 37268817 PMC: 10238420. DOI: 10.1038/s42003-023-04966-0.

References
1.
Oakley R, Laporte S, Holt J, Barak L, Caron M . Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*. J Biol Chem. 2001; 276(22):19452-60. DOI: 10.1074/jbc.M101450200. View

2.
Oakley R, Laporte S, Holt J, Barak L, Caron M . Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem. 1999; 274(45):32248-57. DOI: 10.1074/jbc.274.45.32248. View

3.
Feinstein T, Yui N, Webber M, Wehbi V, Stevenson H, King Jr J . Noncanonical control of vasopressin receptor type 2 signaling by retromer and arrestin. J Biol Chem. 2013; 288(39):27849-60. PMC: 3784700. DOI: 10.1074/jbc.M112.445098. View

4.
Santini F, Gaidarov I, Keen J . G protein-coupled receptor/arrestin3 modulation of the endocytic machinery. J Cell Biol. 2002; 156(4):665-76. PMC: 2174075. DOI: 10.1083/jcb.200110132. View

5.
Kang D, Tian X, Benovic J . Role of β-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol. 2014; 27:63-71. PMC: 3971387. DOI: 10.1016/j.ceb.2013.11.005. View